RDD Symposium was co-hosted with Takeda Pharmaceutical Co.,Ltd.

2022.02.06 19:11

As the RDD Japan organizing office, we cooperated in planning the RDD event hosted by Takeda Pharmaceutical Company Limited. Kunihiro Nishimura, Vice President of Takeda Pharmaceutical Company Limited, served as the moderator, and Yukiko Nishimura, President of Takeda Pharmaceutical Company Limited, moderated the panel discussion.

[Theme] Toward an Inclusive Society for People with Rare Diseases

[Date] Sunday, February 6, 2022, 15:00 to 16:40  Online distribution from DAWN ver. βThe alter ego robot café.

[Speakers] 

Takayuki Shirase,  Kyoto University Museum

Ayako Ozawa Muscular dystrophy patient             

Akihime Yuki, Co-Founder, and COO, Oly Research Institute, Inc.

<Panel Discussion Facilitator

Yukiko Nishimura, RDD Japan Secretariat

 

[Video Message]

Daisuke Ikezaki, Charcot-Marie-Tooth disease sufferers/ wheelchair rugby para-athlete

 

Co-sponsored by Takeda Pharmaceutical Company Limited and RDD Japan Organizing Office

 

The symposium report can be found here. (in Japanese)

https://genetics.qlife.jp/news/20220216-j213?fbclid=IwAR3mzwo2Oj8m5UV4D2cQNSOtxiMrGj0MW4iP4IBB__hFebmS82yt2e-TW1Y